Biotech Values

[genisi]

AMGN - health care reform impact :

"Provisions of the U.S. health-care overhaul law, including one that increases fees paid by drugmakers, cost Amgen $33 million in the first quarter and will increase costs by $200 million to $250 million this year, said George Morrow, the company’s executive vice president for global operations, in a conference call with analysts. The company won’t benefit from greater numbers of Americans being covered by health insurance until 2014, he said."

http://www.bloomberg.com/apps/news?pid=20601202&sid=ahFnRezRZRLQ